ReviewOne health (Amsterdam, Netherlands)2026
Strengthening One Health Antimicrobial Resistance Surveillance in Bangladesh: Insights from the Fleming fund country grant.
Review in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is an escalating global public health concern, with particularly severe implications for low and middle-income countries such as Bangladesh. In Bangladesh context, fragmented surveillance systems and the extensive use of antimicrobials across human, animal, and aquaculture sectors contribute to the rapid emergence and spread of resistance. Strengthening integrated surveillance through a One Health approach is therefore crucial to support effective policy development and response strategies. This review outlines the policy, implementation, and key outcomes of the Fleming Fund Country Grant in Bangladesh between 2020 and 2025. It draws upon multiple data sources, including programme reports, routine AMR surveillance data, laboratory capacity-building initiatives, and stakeholder engagement activities across human, animal, aquaculture, and environmental sectors. Through this initiative, a coordinated national AMR surveillance network was established, comprising 20 laboratories across multiple sectors, including three designated national reference laboratories. The initiative strengthened surveillance through the introduction of standardized protocols and SOPs, improved diagnostic capacity, skilled workforce, and implementation of laboratory quality assurance systems, including EQA and NEQA. These measures enhanced the accuracy, consistency, and reliability of AMR surveillance data. In addition, the establishment of a national AMR data integration platform facilitated real time data sharing and evidence-based decision-making. A total of 208,346 bacterial isolates were analyzed, with AST results reported to the AMR dashboard across the human, and animal, health sectors. Overall, the Fleming Fund programme has made a substantial contribution to strengthening integrated AMR surveillance in Bangladesh by operationalizing a One Health framework. Continued political commitment, increased domestic investment, and the institutionalization of surveillance systems will be essential to sustain these gains and ensure long-term resilience against AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.